A deep learning-based automated pipeline for colorectal cancer detection in contrast-enhanced CT images.

Colorectal cancer (CRC) is the third most commonly diagnosed malignancy worldwide and a leading cause of cancer-related mortality. This study aims to investigate an automatic detection pipeline for identification and localization of the primary CRC in portal venous phase contrast-enhanced CT scans, which is a crucial first step for downstream CRC staging, prognostication, and treatment planning. We propose a deep learning-based automated detection pipeline using YOLOv11 as the baseline architecture. A ResNet50 module was incorporated into the YOLOv11 backbone to enhance image feature extraction. Additionally, a scale-adaptive loss function, which introduces an adaptive coefficient and a scaling factor to adaptively measure the Intersection over Union (IoU) and center point distance for improving box regression performance, was designed to further improve detection performance. The proposed pipeline achieved a recall of 0.8092, precision of 0.8187, and F-1 score of 0.8139 for CRC detection on our in-house dataset at the patient level (inter-patient evaluation) and a recall of 0.9949, precision of 0.9894, and F-1 score of 0.9921 at the slice level (intra-patient evaluation). Validation on an external public dataset demonstrated that our pipeline, when trained on a patient-level in-house dataset, obtained a recall of 0.8283, precision of 0.8414, and F-1 score of 0.8348 and, when trained on a slice-level in-house dataset, achieved a recall of 0.6897, precision of 0.7888, and F-1 score of 0.7358, outperforming existing representative detection methods. The superior CRC detection performance on the in-house CT dataset and state-of-the-art generalization performance on the public dataset (with a 31.97 %age point improvement in detection sensitivity (recall) over the next closest state-of-the-art method), highlight the potential translational value of our pipeline for CRC clinical decision support, conditional upon validation in larger cohorts.